Business Standard

Private equity firm Affirma Capital to invest $50 mn in Tirupati Group

Established in 2005, Tirupati Group has since grown to become a leading value added contract research and manufacturing company for nutraceutical supplements in India

money, investment, private equity, PE, banks
Premium

Representative Image

BS Reporter New Delhi
Affirma Capital, a newly formed, independent private equity firm to be managed by the team from Standard Chartered Private Equity, has agreed to invest in the Tirupati Group, a leading nutraceuticals-focussed contract research and manufacturing company in India. Affirma will invest $50 million to support the organic and inorganic growth initiatives of the company. Affirma Capital/Stanchart PE is one of the three PE firms that hold a stake in CCD.

Established in 2005, Tirupati Group has since grown to become a leading value added contract research and manufacturing company for nutraceutical supplements in India. Tirupati has developed capabilities to cater to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in